Note: Ingredients listed on restricted chemical lists
EC/CAS
216-823-5/1675-54-3
Name of the chemical
2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
Concentration
15≤x<16,5
EC/CAS
271-846-8/68609-97-2
Name of the chemical
Oxirane, mono[(C12-14-alkyloxy)methyl] derivs
Concentration
4,5≤x<5
EC/CAS
202-849-4/100-41-4
Name of the chemical
Ethylbenzene
Concentration
0≤x<0,05
General Information
Version
6
Revision date
2023-02-28
Product name
EGLUE A
Product name
EGLUE A
Identification on the label/Trade name
BISAZZA SPA
1.2.2. Uses advised against
Other different uses
Icons in SDS
Company Information
company name
BISAZZA SPA
e-mail address of the competent person responsible for the Safety Data Sheet
safety@bisazza.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
The product is classified as hazardous pursuant to the provisions set forth in (EC) Regulation
2.2 Label elements
Hazard labelling pursuant to EC Regulation
Signal word
Warning
Hazard statements
H319 Causes serious eye irritation. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H412 Harmful to aquatic life with long lasting effects. EUH205 Contains epoxy constituents. May produce an allergic reaction.
Precautionary statements
P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing / eye protection / face protection. P302+P352 IF ON SKIN: wash with plenty of water and soap. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P333+P313 If skin irritation or rash occurs: Get medical advice / attention. P337+P313 If eye irritation persists: Get medical advice / attention.
Contains
FORMALDEHYDE, OLIGOMERIC REACTION PRODUCTS WITH 1-CHLORO-2,3-EPOXYPROPANE AND PHENOL POLYPROPYLEN GLYCOL DIGLICIDY ETHER OXIRANE, MONO[(C12-14-ALKYLOXY)METHYL] DERIVATIVES BIS[4-(2,3-EPOXYPROPOXY)PHENYL]PROPANE
2.3 Other hazards
On the basis of available data, the product does not contain any PBT or vPvB in percentage ≥ than 0,1%. The product does not contain substances with endocrine disrupting properties in concentration >= 0.1%.
